BUY IPCA Laboratories Limited — Motilal Oswal
byMotilal OswalHorizon: NA (inferred 1 year)27 Dec 2024via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
1 other SEBI-registered advisor has an active long-term BUY call on this stock
Advisor consensus · same horizon·17 Nov · 1mo ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on IPCA Laboratories
- BUY — Vikas Sethi, Sethi Finmart23 Oct 2026 · ~1 year · target ₹2,250 · Active
- BUY — Kunal Saraogi23 Oct 2026 · ~3 months · target ₹2,350 · Active
- BUY — Manas Jaiswal22 Oct 2026 · ~2 weeks · target ₹2,000 · Active
- BUY — Vikas Sethi, Sethi Finmart8 Oct 2026 · ~1 year · target ₹2,300 · SL hit
- BUY — Sudeep Shah, SBICAP Securities5 Oct 2026 · ~3 months · target ₹2,040 · SL hit
More from Motilal Oswal
- BUY Colgate Palmolive (India)22 Oct 2026 · ~1 year · target ₹2,000 · Active
- BUY Sapphire Foods India22 Oct 2026 · ~1 year · target ₹245 · Active
- BUY CIE Automotive India22 Oct 2026 · ~1 year · target ₹440 · Active
- BUY CREDITACCESS GRAMEEN22 Oct 2026 · ~1 year · target ₹1,450 · Active
- BUY KEI Industries22 Oct 2026 · ~1 year · target ₹5,180 · Active

